Literature DB >> 17728073

Heterotopic ossification: review of histologic findings and tissue distribution in a 10-year experience.

Katharine Liu1, Sheryl Tripp, Lester J Layfield.   

Abstract

Heterotopic ossification (HO) within tissues involved by a pathologic process is a well-recognized phenomenon. It is most frequently observed in atherosclerotic plaques, in soft tissue around joints, and in the central nervous system. Less frequently, carcinomas and some benign neoplasms will undergo heterotopic ossification. We performed a retrospective review of our experience with HO over a 10-year period to determine the frequency and tissue site distribution of heterotopic ossification. A computerized review of surgical pathology records of approximately 126,000 reports revealed 85 cases in which heterotopic ossification, ectopic bone or metaplastic bone was specifically mentioned in the surgical pathology diagnosis. Twenty-two cases were neoplasms of non-osseous tissues, and 63 cases were non-neoplastic lesions. Immunohistochemical staining for bone morphogenic proteins (BMP) 1, 4, and 6 was performed. Fourteen cases showed staining for BMP-1, 22 cases showed staining for BMP-4, and five cases showed weak staining for BMP-6. HO is a relatively infrequent finding and is more commonly seen in degenerative and reparative conditions than in neoplasms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728073     DOI: 10.1016/j.prp.2007.05.014

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  13 in total

1.  Osseous metaplasia in a juvenile polyp: a rare case report in India.

Authors:  Nanigopal Bhattacharya; Tirthankar Sarkar
Journal:  J Clin Diagn Res       Date:  2013-09-10

2.  Delivery of siRNA silencing Runx2 using a multifunctional polymer-lipid nanoparticle inhibits osteogenesis in a cell culture model of heterotopic ossification.

Authors:  Swati Mishra; Asa D Vaughn; David I Devore; Charles M Roth
Journal:  Integr Biol (Camb)       Date:  2012-12       Impact factor: 2.192

3.  Foxc2 induces Wnt4 and Bmp4 expression during muscle regeneration and osteogenesis.

Authors:  M C Gozo; P-J Aspuria; D-J Cheon; A E Walts; D Berel; N Miura; B Y Karlan; S Orsulic
Journal:  Cell Death Differ       Date:  2013-05-03       Impact factor: 15.828

Review 4.  Ossification of abdominal scar tissue: a case series with a translational review on its development.

Authors:  E M Fennema; J de Boer; W J Mastboom
Journal:  Hernia       Date:  2014-03-26       Impact factor: 4.739

5.  Osseous Metaplasia in an Inflammatory Polyp of the Rectum: A Case Report and Review of the Literature.

Authors:  Brian R Odum; Matthew L Bechtold; Alberto Diaz-Arias
Journal:  Gastroenterology Res       Date:  2012-03-20

6.  Reactive oxygen and nitrogen species induce protein and DNA modifications driving arthrofibrosis following total knee arthroplasty.

Authors:  Theresa A Freeman; Javad Parvizi; Craig J Della Valle; Marla J Steinbeck
Journal:  Fibrogenesis Tissue Repair       Date:  2009-11-13

Review 7.  Pleural chondroid metaplasia in a background of IgG4 plasma cell rich chronic inflammatory infiltrate: report of a rare case with review of literature.

Authors:  M Spinelli; A Datta; M A Montero Fenandez; P Viola
Journal:  Pathologica       Date:  2019-12

8.  [About a rare form of myositis ossificans progressiva of Münchmeyer].

Authors:  Hicham Sator; Rachida Dafiri; Latifa Chat
Journal:  Pan Afr Med J       Date:  2015-04-28

Review 9.  Proliferative and non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle and mesothelium.

Authors:  Peter Greaves; Luc Chouinard; Heinrich Ernst; Lars Mecklenburg; Ingrid M Pruimboom-Brees; Matthias Rinke; Susanne Rittinghausen; Stéphane Thibault; Jasmin Von Erichsen; Toshinori Yoshida
Journal:  J Toxicol Pathol       Date:  2013       Impact factor: 1.628

Review 10.  Long-term Consequences of Traumatic Brain Injury in Bone Metabolism.

Authors:  Nikita M Bajwa; Chandrasekhar Kesavan; Subburaman Mohan
Journal:  Front Neurol       Date:  2018-03-05       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.